Stock listing

NASDAQ:BBLG Bone Biologics Corp Stock

Home listing (NASDAQ) of Bone Biologics Corp

Follow Bone Biologics Corp into a list and get an email when it puts out news.

Share price · NASDAQ:BBLG

$0.269 USD -0.022 (-7.7%)

Close on Nov 20, 2026

Past year -81.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.268 – $0.285 USDNov 20, 2026
Volume
36,490 sharesNov 20, 2026
Market cap
$909,962 USDAt the close on Nov 20, 2026 · price × 3.39M shares outstanding
52-week range
$0.266 – $2.390 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$112,869 USDMedian day 38,557 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Bone Biologics Corp logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BBLG · Home$0.269 USD-0.022 (-7.7%)36,490$0.276$0.285$0.268$0.291Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BBLG · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.269-0.022-7.7%$0.276$0.285$0.26836,490
$0.291-0.018-5.9%$0.317$0.317$0.28138,557
$0.309+0.015+5.1%$0.311$0.323$0.28239,735
$0.294-0.031-9.5%$0.326$0.350$0.26697,241
$0.325-0.075-18.7%$0.375$0.392$0.325297,701
$0.400+0.050+14.3%$0.367$0.476$0.3207,911,964
$0.350+0.009+2.6%$0.343$0.375$0.34015,604
$0.341+0.010+3.0%$0.348$0.358$0.32731,532
$0.331-0.002-0.6%$0.334$0.390$0.32254,521
$0.333+0.010+3.0%$0.338$0.350$0.315135,469
$0.324-0.023-6.7%$0.348$0.348$0.32240,397
$0.347-0.006-1.8%$0.378$0.380$0.34722,917
$0.354-0.017-4.7%$0.367$0.371$0.35236,655
$0.371-0.010-2.5%$0.385$0.388$0.36723,773
$0.380-0.008-2.0%$0.403$0.403$0.37614,407
$0.388-0.004-0.9%$0.409$0.410$0.38718,284
$0.392+0.024+6.5%$0.407$0.420$0.38946,671
$0.368-0.009-2.4%$0.390$0.390$0.361121,145
$0.377-0.018-4.6%$0.390$0.407$0.37025,825
$0.395-0.011-2.7%$0.407$0.407$0.39110,000
$0.406-0.014-3.3%$0.410$0.417$0.39225,100
$0.420-0.010-2.3%$0.405$0.425$0.40515,600
$0.430+0.019+4.6%$0.425$0.443$0.41114,500
$0.411+0.016+4.1%$0.430$0.443$0.39019,100
$0.395+0.007+1.8%$0.405$0.409$0.38559,700
$0.388-0.027-6.5%$0.397$0.404$0.379119,300
$0.415-0.015-3.5%$0.418$0.418$0.39158,100
$0.430-0.025-5.5%$0.442$0.460$0.40059,600
$0.455-0.012-2.6%$0.466$0.466$0.44033,700
$0.467-0.002-0.4%$0.471$0.492$0.45836,300
$0.469-0.019-3.9%$0.475$0.475$0.4689,700
$0.488+0.008+1.7%$0.462$0.488$0.46217,500
$0.480-0.005-1.0%$0.496$0.496$0.46253,700
$0.485+0.010+2.1%$0.474$0.495$0.46026,200
$0.4750.0000.0%$0.479$0.481$0.46620,600
$0.475-0.021-4.2%$0.470$0.481$0.46623,500
$0.4960.0000.0%$0.491$0.496$0.47536,700
$0.4960.0000.0%$0.486$0.496$0.47915,900
$0.4960.0000.0%$0.480$0.496$0.48033,400
$0.496+0.005+1.0%$0.488$0.496$0.47057,600
$0.491-0.015-3.0%$0.529$0.550$0.476229,200
$0.506+0.021+4.3%$0.470$0.550$0.460448,700
$0.485+0.009+1.9%$0.495$0.499$0.46653,200
$0.476-0.043-8.3%$0.508$0.519$0.46765,700
$0.519+0.019+3.8%$0.520$0.525$0.500119,900
$0.500-0.038-7.1%$0.469$0.539$0.428465,200
$0.538-0.002-0.4%$0.531$0.550$0.5314,176,500
$0.5400.0000.0%$0.532$0.580$0.510103,800
$0.540-0.011-2.0%$0.540$0.568$0.54024,300
$0.551-0.010-1.8%$0.561$0.565$0.55011,300
$0.561+0.007+1.3%$0.562$0.575$0.55117,500
$0.554-0.006-1.1%$0.590$0.590$0.55054,900
$0.560-0.008-1.4%$0.582$0.585$0.56014,800
$0.568+0.010+1.8%$0.577$0.577$0.54415,200
$0.558+0.008+1.5%$0.580$0.580$0.55057,600
$0.550-0.013-2.3%$0.560$0.565$0.54095,500
$0.563-0.014-2.4%$0.564$0.564$0.55025,900
$0.577-0.038-6.2%$0.588$0.588$0.55789,900
$0.6150.0000.0%$0.600$0.615$0.58028,300
$0.615-0.001-0.2%$0.591$0.619$0.59075,800
$0.616+0.011+1.8%$0.584$0.616$0.58072,100
$0.605-0.003-0.5%$0.593$0.607$0.58824,100
$0.608-0.018-2.9%$0.622$0.622$0.58443,300
$0.626+0.021+3.5%$0.600$0.628$0.59083,400
$0.605-0.035-5.5%$0.630$0.630$0.60083,800

Splits

3 splits since 2023 · NASDAQ:BBLG · every price before a split is adjusted for it

DayRatioWhat
1-for-6Consolidation
1-for-8Consolidation
1-for-30Consolidation
Ticker
NASDAQ:BBLG
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Bone Biologics Corp news

Bone Biologics Corp on 6ix

News releases
8 in the last 12 months · 36 in all · newest Sep 8, 2026 · oldest 2020
Decks
5 decks · latest August 2026

Where Bone Biologics Corp is listed

ListingExchangeCountryCurrency
NASDAQ:BBLG · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BBLGBOATSUnited StatesUSD

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$5.18M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.1×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.05

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
12.20 USD · Analysts' mean
EPS, year to Dec 2026
-1.18 · 1 analyst

Team and board

Officers

OfficerRole
Jeff FrelickChief Executive Officer

Board

DirectorRole
Don HankeyChairman

Events

QuarterResultsShare move
Q3 2026Oct 26, 2026 · After close−2.4%
Q2 2026Aug 14, 2026 · After close+0.8%
Q4 2025Mar 2, 2026 · After close+5.7%
Q3 2025Nov 14, 2025 · After close+1.7%
Q2 2025Aug 14, 2025 · After close−6.4%
Q1 2025May 12, 2025 · After close+6.2%
Q4 2024Feb 26, 2025 · After close−5.4%
Q3 2024Nov 14, 2024 · After close−7.8%
Q2 2024Aug 9, 2024 · After close−4.1%
Q1 2024May 14, 2024 · After close−1.3%
All 20 quarters
QuarterResultsShare move
Q4 2023Feb 20, 2024 · After close−19.2%
Q3 2023Nov 14, 2023 · After close+8.6%
Q2 2023Aug 14, 2023 · After close−35.0%
Q1 2023May 15, 2023 · After close+4.3%
Q4 2022Mar 30, 2023 · After close+5.3%
Q3 2022Nov 14, 2022 · Before open−6.0%
Q2 2022Aug 11, 2022 · After close+1.6%
Q1 2022May 13, 2022 · After close−0.7%
Q4 2021Mar 15, 2022 · After close−3.9%
Quarter to Sep 30, 2021Nov 16, 2021 · After close−4.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2026)Investor deck17 slidesAugust 2026
Investor Presentation (December 2024)Investor deck17 slidesDecember 2024
Investor Presentation (January 2022)Investor deck19 slidesJanuary 2022
Investor Presentation (2019)Investor deck21 slides2019
Investor Presentation (July 2018)Investor deck19 slidesJul 6, 2018

Open Decks

Financings

RaiseDate
Private placement of private placement including Series F warrants and Series G warrants
Closed: US$3M raised · US$1.42 a share · Warrants at US$1.42 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Fund clinical trials, maintain and extend patent portfolio, working capital and general corporate purposes
Jul 23, 2026
Public offering of common stock (or common stock equivalents) with Series D and Series E warrants
Closed: US$5M raised · US$4 a share · Warrants at US$4 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Fund clinical trials, maintain and extend patent portfolio, working capital and general corporate purposes
Jun 30, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.07B1.07B1.07B
Research and development1.06M2.13M6.91M1.58M82.0K340.7K1.10M104.5K1.42M10.2M
Operating income-3.23M-4.22M-9.43M-3.67M-1.10M-825.0K-2.45M-2.79M-2.63M-20.4M
Depreciation and amortization509696700
EBITDA-2.45M-2.79M-2.63M-20.4M
Income before tax-1.61M-1.82M-3.42M-4.43M-7.05M-25.9M
Income tax1.60K1.60K1.60K1.73K1.60K2.24K
Net income-3.11M-4.11M-8.95M-1.48M-1.61M-1.82M-3.42M-4.43M-7.05M-25.9M
Earnings per share, basic-2.65-28.96-34.01-31.15-0.35-0.63-0.47-0.88-1.81-0.69
Earnings per share, diluted-2.65-28.96-34.01-31.15-0.35-0.63-0.47-0.88-1.81-0.69

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents5.33M3.33M3.03M7.54M6.68M24.1K955.4K690.3K620.4K
Current assets5.80M3.86M3.74M8.50M30.8K1.04M795.5K700.9K
Property, plant and equipment50146242
Total assets5.80M3.86M3.74M8.50M6.68M030.8K1.04M795.7K701.1K
Accounts payable465.4K42.9K125.2K216.9K226.5K
Current liabilities418.6K377.7K831.4K2.55M99.9K13.7M578.4K9.64M961.8K1.50M
Total liabilities418.6K377.7K831.4K2.55M99.9K13.7M11.9M9.64M9.19M9.06M
Shareholders' equity5.38M3.48M2.91M5.95M6.58M-13.7M-11.9M-8.60M-8.40M-8.36M
Shares outstanding1.80M492.4K534.2K63.8K10.4M12.3M30.7M26.4M4.33M38.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-2.69M-4.12M-9.56M-3.57M-1.23M-426.9K-3.25M-4.10M-3.33M-7.33M
Cash from financing4.70M4.42M5.04M4.43M7.90M402.8K2.32M4.37M3.40M6.83M
Change in cash2.01M298.6K-4.51M862.9K6.68M-24.1K-931.2K265.1K69.9K-494.7K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 10, 2026Big-stake noticeSEC
10-Q · Quarterly reportOct 26, 2026Quarterly reportSEC
25-NSEOct 13, 2026Other filingsSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
8-K · Current reportSep 29, 2026Meeting outcomeSEC
8-K · Current reportSep 16, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
DEF 14A · Proxy statementAug 28, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementAug 18, 2026Meeting noticeSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
EFFECT · Notice that a registration is effectiveJul 27, 2026Other filingsSEC
424B3 · ProspectusJul 24, 2026Offer documentSEC
8-K · Current reportJul 23, 2026Current reportSEC
DEFA14A · Additional proxy materialJul 20, 2026Meeting noticeSEC
S-3 · Registration statementJul 17, 2026Offer documentSEC
8-K · Current reportJul 16, 2026Current reportSEC
8-K · Current reportJul 9, 2026Material contractSEC
ARS · Annual report to shareholdersJul 2, 2026Annual reportSEC
DEFA14A · Additional proxy materialJul 2, 2026Meeting noticeSEC
DEF 14A · Proxy statementJul 2, 2026Meeting noticeSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMar 13, 2026Current reportSEC
424B5 · ProspectusMar 13, 2026Offer documentSEC
10-K · Annual reportMar 2, 2026Annual reportSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
8-K · Current reportJan 8, 2026Current reportSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 7, 2025Big-stake noticeSEC
S-8 · Registration statement for employee plansSep 26, 2025Offer documentSEC
8-K · Current reportSep 4, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveSep 3, 2025Other filingsSEC
CORRESP · Letter to the SECAug 29, 2025Other filingsSEC
S-3/A · Registration statement, amendedAug 29, 2025Offer documentSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeJul 3, 2025Big-stake noticeSEC
UPLOAD · Letter from the SECJul 1, 2025Other filingsSEC
8-K · Current reportJun 30, 2025Material contractSEC
424B4 · ProspectusJun 30, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveJun 30, 2025Other filingsSEC
8-K · Current reportJun 26, 2025Current reportSEC
CORRESP · Letter to the SECJun 24, 2025Other filingsSEC
S-3 · Registration statementJun 24, 2025Offer documentSEC
S-1 · Registration statementJun 24, 2025Offer documentSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
8-K · Current reportJun 6, 2025Current reportSEC
8-K · Current reportMay 30, 2025Management or board changeSEC
10-Q · Quarterly reportMay 12, 2025Quarterly reportSEC
ARS · Annual report to shareholdersApr 23, 2025Annual reportSEC
DEF 14A · Proxy statementApr 23, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 11, 2025Meeting noticeSEC
8-K · Current reportApr 11, 2025Current reportSEC
8-K · Current reportApr 1, 2025Current reportSEC
UPLOAD · Letter from the SECMar 24, 2025Other filingsSEC
DRS · Draft registration statementMar 17, 2025Offer documentSEC
DRSLTR · Letter to the SEC with a draftMar 17, 2025Other filingsSEC
10-K · Annual reportFeb 26, 2025Annual reportSEC
4 · Change in ownershipJan 21, 2025Insider tradeSEC
4 · Change in ownershipJan 21, 2025Insider tradeSEC
8-K · Current reportDec 13, 2024Current reportSEC
424B5 · ProspectusDec 13, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
8-K · Current reportOct 21, 2024Management or board changeSEC
4 · Change in ownershipOct 18, 2024Insider tradeSEC
3 · Initial statement of ownershipOct 18, 2024Insider tradeSEC
8-K · Current reportOct 4, 2024Management or board changeSEC
8-K · Current reportSep 27, 2024Material contractSEC
424B5 · ProspectusSep 27, 2024Offer documentSEC
4 · Change in ownershipSep 19, 2024Insider tradeSEC
4 · Change in ownershipSep 19, 2024Insider tradeSEC
4 · Change in ownershipSep 19, 2024Insider tradeSEC
8-K · Current reportSep 19, 2024Meeting outcomeSEC
EFFECT · Notice that a registration is effectiveAug 27, 2024Other filingsSEC
CORRESP · Letter to the SECAug 22, 2024Other filingsSEC
UPLOAD · Letter from the SECAug 21, 2024Other filingsSEC
S-3 · Registration statementAug 12, 2024Offer documentSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
ARS · Annual report to shareholdersAug 8, 2024Annual reportSEC
DEFA14A · Additional proxy materialAug 8, 2024Meeting noticeSEC
DEF 14A · Proxy statementAug 8, 2024Meeting noticeSEC
8-K · Current reportAug 2, 2024Material contractSEC
SC 13G/A · Big-stake notice, amendedJun 28, 2024Big-stake noticeSEC
8-K · Current reportJun 20, 2024Current reportSEC
10-Q · Quarterly reportMay 14, 2024Quarterly reportSEC
8-K · Current reportMar 15, 2024Management or board changeSEC
SC 13G · Big-stake noticeMar 14, 2024Big-stake noticeSEC
8-K · Current reportMar 6, 2024Material contractSEC
EFFECT · Notice that a registration is effectiveMar 5, 2024Other filingsSEC
424B4 · ProspectusMar 4, 2024Offer documentSEC
CORRESP · Letter to the SECMar 1, 2024Other filingsSEC
8-K · Current reportMar 1, 2024Current reportSEC
CORRESP · Letter to the SECFeb 29, 2024Other filingsSEC
CORRESP · Letter to the SECFeb 28, 2024Other filingsSEC
CORRESP · Letter to the SECFeb 27, 2024Other filingsSEC
S-1/A · Registration statement, amendedFeb 26, 2024Offer documentSEC
S-1/A · Registration statement, amendedFeb 23, 2024Offer documentSEC
10-K · Annual reportFeb 21, 2024Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
UPLOAD · Letter from the SECFeb 5, 2024Other filingsSEC
S-1 · Registration statementJan 30, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveJan 25, 2024Other filingsSEC
CORRESP · Letter to the SECJan 22, 2024Other filingsSEC
4 · Change in ownershipJan 19, 2024Insider tradeSEC
4 · Change in ownershipJan 19, 2024Insider tradeSEC
S-3/A · Registration statement, amendedJan 17, 2024Offer documentSEC
8-K · Current reportJan 12, 2024Current reportSEC
UPLOAD · Letter from the SECJan 11, 2024Other filingsSEC
8-K · Current reportJan 11, 2024Management or board changeSEC
4 · Change in ownershipJan 10, 2024Insider tradeSEC
3 · Initial statement of ownershipJan 10, 2024Insider tradeSEC
8-K · Current reportJan 10, 2024Current reportSEC
S-3 · Registration statementJan 5, 2024Offer documentSEC
8-K · Current reportJan 2, 2024Management or board changeSEC
SC 13G/A · Big-stake notice, amendedJan 2, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedDec 20, 2023Big-stake noticeSEC
8-K · Current reportDec 18, 2023Current reportSEC
8-K · Current reportDec 13, 2023Meeting outcomeSEC
DNov 29, 2023Other filingsSEC
SC 13G · Big-stake noticeNov 27, 2023Big-stake noticeSEC
8-K · Current reportNov 20, 2023Material contractSEC
424B5 · ProspectusNov 20, 2023Offer documentSEC
DEF 14A · Proxy statementNov 20, 2023Meeting noticeSEC
10-K/A · Annual report, amendedNov 20, 2023Annual reportSEC
10-Q · Quarterly reportNov 14, 2023Quarterly reportSEC
PRE 14A · Preliminary proxy statementNov 9, 2023Meeting noticeSEC
8-K · Current reportOct 24, 2023Current reportSEC
8-K · Current reportSep 29, 2023Current reportSEC
4 · Change in ownershipSep 20, 2023Insider tradeSEC
4 · Change in ownershipSep 20, 2023Insider tradeSEC
4 · Change in ownershipSep 20, 2023Insider tradeSEC
S-8 · Registration statement for employee plansSep 15, 2023Offer documentSEC
4 · Change in ownershipSep 14, 2023Insider tradeSEC
8-K · Current reportSep 12, 2023Meeting outcomeSEC
4 · Change in ownershipSep 12, 2023Insider tradeSEC
4 · Change in ownershipSep 7, 2023Insider tradeSEC
4 · Change in ownershipSep 5, 2023Insider tradeSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
ARS · Annual report to shareholdersAug 3, 2023Annual reportSEC
DEFA14A · Additional proxy materialAug 3, 2023Meeting noticeSEC
DEF 14A · Proxy statementAug 3, 2023Meeting noticeSEC
8-K · Current reportJul 5, 2023Current reportSEC
SC 13G · Big-stake noticeJun 26, 2023Big-stake noticeSEC
8-K · Current reportJun 16, 2023Material contractSEC
424B4 · ProspectusJun 15, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveJun 15, 2023Other filingsSEC
CORRESP · Letter to the SECJun 13, 2023Other filingsSEC
CORRESP · Letter to the SECJun 13, 2023Other filingsSEC
S-1/A · Registration statement, amendedJun 13, 2023Offer documentSEC
S-1/A · Registration statement, amendedJun 6, 2023Offer documentSEC
8-K · Current reportJun 6, 2023Current reportSEC
8-K · Current reportMay 19, 2023Current reportSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
DEF 14CMay 11, 2023Meeting noticeSEC
UPLOAD · Letter from the SECMay 8, 2023Other filingsSEC
S-1 · Registration statementMay 1, 2023Offer documentSEC
PRE 14CMay 1, 2023Meeting noticeSEC
10-K · Annual reportMar 30, 2023Annual reportSEC
SC 13D/A · Big-stake notice, amendedMar 29, 2023Big-stake noticeSEC
4 · Change in ownershipMar 29, 2023Insider tradeSEC
4 · Change in ownershipMar 8, 2023Insider tradeSEC
4 · Change in ownershipMar 8, 2023Insider tradeSEC
4 · Change in ownershipMar 8, 2023Insider tradeSEC
4 · Change in ownershipMar 8, 2023Insider tradeSEC
4 · Change in ownershipMar 8, 2023Insider tradeSEC
SC 13G · Big-stake noticeFeb 14, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeJan 4, 2023Big-stake noticeSEC
8-K · Current reportDec 21, 2022Management or board changeSEC
8-K · Current reportNov 21, 2022Current reportSEC
10-Q · Quarterly reportNov 14, 2022Quarterly reportSEC
8-K · Current reportOct 25, 2022Current reportSEC
8-K · Current reportOct 13, 2022Current reportSEC
SC 13G · Big-stake noticeOct 11, 2022Big-stake noticeSEC
8-K · Current reportOct 11, 2022Material contractSEC
424B4 · ProspectusOct 11, 2022Offer documentSEC
S-1MEF · Registration of more shares for the same offeringOct 7, 2022Offer documentSEC
S-1MEF · Registration of more shares for the same offeringOct 7, 2022Offer documentSEC
EFFECT · Notice that a registration is effectiveOct 7, 2022Other filingsSEC
S-1/A · Registration statement, amendedOct 4, 2022Offer documentSEC
CORRESP · Letter to the SECOct 4, 2022Other filingsSEC
CORRESP · Letter to the SECOct 4, 2022Other filingsSEC
S-1/A · Registration statement, amendedOct 4, 2022Offer documentSEC
UPLOAD · Letter from the SECSep 30, 2022Other filingsSEC
S-1 · Registration statementSep 23, 2022Offer documentSEC
8-K · Current reportAug 23, 2022Meeting outcomeSEC
10-Q · Quarterly reportAug 11, 2022Quarterly reportSEC
EFFECT · Notice that a registration is effectiveJul 12, 2022Other filingsSEC
CORRESP · Letter to the SECJul 7, 2022Other filingsSEC
UPLOAD · Letter from the SECJul 6, 2022Other filingsSEC
DEF 14A · Proxy statementJul 6, 2022Meeting noticeSEC

This page holds 200 of 487 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Bone Biologics Corp’s releases · as of Oct 26, 2026

Common shares
3,389,057
Fully diluted
3,389,057

Fully diluted

LineSharesAs of
Common shares3,389,057Oct 26, 2026

Warrants and options

Lot
Warrants · US$1.42 · expiry not stated
Warrants · US$4.00 · expire about Jun 2030

Share count over time

CountShares
Oct 26, 20263,389,057

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Armistice Capital, LLC290K8.6%US$144KSep 30, 2026
Hrt Financial LP67,9632.0%US$33,000Sep 30, 2026
Citadel42,1261.2%US$20,907Sep 30, 2026
Virtu Financial LLC20,6940.61%US$10,000Sep 30, 2026
Susquehanna11,9700.35%US$5,941Sep 30, 2026
Tower Research Capital LLC (TRC)2,2440.07%US$1,114Sep 30, 2026
SBI Securities Co., Ltd.3410.01%US$169Sep 30, 2026
Caitong International Asset Management Co., Ltd1<0.01%Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund7,8100.23%US$10,309May 31, 2026
Fidelity Total Market Index Fund6560.02%US$866May 31, 2026

Big stakes

StakeStakeSharesDateFiling
Armistice Capital, LLC9.99%344KSep 30, 2026Schedule 13G
Mitchell P. Kopin9.99%306KSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert Gagnon
Other companies: Purple Biotech Ltd. (Board Member · Since at least Mar 18, 2026); Opus Genetics, Inc. (Chief Financial Officer · Since at least Sep 2, 2025); Verastem, Inc. (Director · Since at least Aug 28, 2018); Harvard Bioscience, Inc. (Director · Since at least Nov 18, 2013); Clean Harbors, Inc. (EVP CFO and Treasurer · Aug 20, 2012 – Sep 11, 2012 · Past); Biogen Inc. (Vice President, Finance · Nov 3, 2010 – Feb 28, 2012 · Past)
Director · Since at least Jan 8, 2024
Amir F. Heshmatpour
Other companies: NeOnc Technologies Holdings, Inc. (CEO, Executive Chairman, and President · Since at least Mar 25, 2025)
Director · Jul 11, 2016 – Jul 14, 2016 · Past
Jim Delshad
Other companies: NeOnc Technologies Holdings, Inc. (Director · Mar 25, 2025 – Mar 26, 2025 · Past)
Director · Sep 19, 2015 – Jan 1, 2018 · Past
Steve La Neve
Other companies: Accuray Incorporated (Chief Executive Officer · Since at least Oct 20, 2025)
CEO & President · Aug 17, 2015 – Feb 16, 2018 · Past
Bret HankeyDirector · Jul 31, 2017 – Jan 2, 2020 · Past
Bruce StroeverDirector · Since at least Oct 26, 2021
Deina H WalshChief Financial Officer · Since at least Jan 3, 2022
Don HankeyChairman of the Board, Director · Jul 16, 2018 – Mar 27, 2023 · Past
Jeff FrelickChief Executive Officer · Since at least Sep 8, 2026
Jeff FrelickChief Executive Officer · Since at least Jan 17, 2024
All 14 people
PersonSeat
Phillip Terry Meikle IIDirector · Since at least Oct 16, 2024
Siddhesh Rajendra AngleDirector · Since at least Oct 15, 2021
William F CoffinDirector · Sep 19, 2015 – Dec 28, 2015 · Past
William Jay TreatChief Technology Officer · Dec 21, 2015 – Mar 14, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Bone Biologics Corp.